Similar articles

• Cyclic nucleotide metabolism in solid tumor tissues.

  Criss WE, Muganda P, Sahai A, Morris HP. Criss WE, et al. Adv Exp Med Biol. 1977 May 22-24;92:489-516. doi: 10.1007/978-1-4615-8852-8_20. Adv Exp Med Biol. 1977. PMID: 24989 Review.
• Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.

  Hickie RA, Thompson WJ, Strada SJ, Couture-Murillo B, Morris HP, Robison GA. Hickie RA, et al. Cancer Res. 1977 Oct;37(10):3599-606. Cancer Res. 1977. PMID: 20224 No abstract available.
• Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.

  DeRubertis FR, Craven PA. DeRubertis FR, et al. Metabolism. 1976 Dec;25(12):1611-25. doi: 10.1016/0026-0495(76)90114-1. Metabolism. 1976. PMID: 186692
• Cyclic nucleotide content and granule cell degeneration in the developing cerebellum of staggerer mice.

  Spinka K, Farber DB, Lolley RN. Spinka K, et al. J Neurochem. 1980 Jun;34(6):1531-4. doi: 10.1111/j.1471-4159.1980.tb11236.x. J Neurochem. 1980. PMID: 6103918 No abstract available.
• Cyclic-GMP-regulated enzymes and their possible physiological functions.

  Walter U. Walter U. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:249-58. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984. PMID: 6145321 Review. No abstract available.